Fremantle Hospital is an Australian public hospital situated on South Terrace in central Fremantle, southwest of Perth, Western Australia.

During the past decade, Fremantle Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 17 clinical trials were completed, i.e. on average, 283.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fremantle Hospital" #1 sponsor was "Boston Scientific Corporation" with 5 trials, followed by "Gilead Sciences" with 4 trials sponsored, "Human Genome Sciences Inc." with 3 trials sponsored, "Kirby Institute" with 3 trials sponsored and "Australasian Gastro-Intestinal Trials Group" with 3 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fremantle Hospital" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator, "Lymphoma Trials Office" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Fremantle Hospital" are "Coronary Artery Disease" (7 trials), "Lymphoma" (4 trials), "Chronic Hepatitis C" (3 trials), "Crohn's Disease" (3 trials) and "Hepatitis C" (3 trials). Many other conditions were trialed in "Fremantle Hospital" in a lesser frequency.

Most popular intervention types in "Fremantle Hospital" are "Drug" (40 trials), "Device" (10 trials), "Biological" (8 trials), "Other" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ribavirin" (4 trials), "Paclitaxel" (3 trials), "rituximab" (3 trials) and "Adefovir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fremantle Hospital" are 56 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fremantle Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Fremantle Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Fremantle Hospital, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 4 trials that are defined as “Not Applicable".